Go to contents Go to menus

UOS News

UOS News


Joint Research Team from the University of Seoul, The Catholic University of Korea Seoul St. Mary’s Hospital, and FLONICS Selected for a New Project Under the “Quantum Computing–Based Quantum Advantage Challenge Research Program”
대외협력과 (REG_DATE : 2026-11-12)



- A first step toward new horizons in cardiovascular precision medicine, backed by KRW 2.5 billion in funding over three years

- The team’s third major achievement, following the U.S. NIH Quantum Computing Challenge and the Cleveland Clinic Quantum Innovation Catalyzer Program



A joint research team from the University of Seoul, The Catholic University of Korea Seoul St. Mary’s Hospital, and FLONICS was recently selected for a new project under the “2026 Quantum Computing–Based Quantum Advantage Challenge Research Program,” organized by the Ministry of Science and ICT and the National Research Foundation of Korea. 


The research aims to improve the speed and accuracy of computational fluid dynamics (CFD) analysis of cardiovascular diseases using quantum algorithms and to identify the conditions under which quantum computing offers an advantage in clinical settings. The team includes Doyeol Ahn, Distinguished Professor Emeritus at the University of Seoul (CEO of Singularity Quantum); Jung Im Jung, Kyongmin Beck, and Su Yon Chang, professors from the Department of Radiology at Seoul St. Mary’s Hospital; Jong-Chan Youn (Principal Investigator), Young Choi, and Jaeho Seung, professors from the Department of Cardiology at the Cardio-Cerebro-Vascular Hospital; Hojin Ha, CEO of FLONICS; and Kyuhan Lee, Director of the FLONICS Research Institute.


This project focuses on numerically verifying “when and under what conditions quantum computers actually outperform classical computers (quantum advantage).” This focus reflects the fact that current quantum computers are still in the Noisy Intermediate-Scale Quantum (NISQ) stage, where the key challenge is to reduce errors while minimizing the number of circuits and measurements.


 The research will be conducted over a period of two years and six months, from 2026 to 2028, with KRW 2.5 billion in government research funding. The initial phase will begin with the development of a 3D deep-learning segmentation model that automatically segments the heart, left atrium, and aorta, followed by the construction of a quantum-based hemodynamic model and the validation of results in actual patient cases using 4D Flow MRI. The ultimate goal is for quantum-based CFD to achieve at least 95% agreement with conventional classical CFD. The research will initially focus on atrial fibrillation—the most common sustained arrhythmia, affecting 2–3% of the general population—and will subsequently expand to other heart diseases.


Cardiovascular diseases are complex conditions with diverse causes and symptoms that carry a high risk of mortality and long-term disability; however, patient-specific, personalized diagnosis and treatment based on hemodynamics—the core of their pathophysiology—remain largely unavailable in practice. In particular, in cases of atherosclerosis, where blood vessels narrow, and in structures such as the left atrium, where blood flow is prone to stagnation, blood-flow velocity, pressure, and the frictional force exerted on the vessel walls (wall-shear stress) can influence thrombus formation or myocardial damage. However, existing anatomical imaging methods, such as CT and MRI, can show how much a blood vessel has narrowed but cannot determine the velocity and pressure of the blood flow. 


CFD makes it possible to calculate blood-flow velocity, pressure, and wall-shear stress by applying the physical laws of fluid dynamics to such anatomical images. Despite continued attempts to apply this approach in clinical practice, its use has been limited by long computation times when increasing the number of mesh elements to improve accuracy or when handling highly nonlinear problems and complex boundary conditions.


The research team believes that quantum computers can overcome this bottleneck by performing highly accurate, high-density computations in a much shorter time. This is because, unlike classical computers that process 0s and 1s sequentially, quantum computers can explore a vast number of possibilities simultaneously by leveraging the principle of superposition, which allows multiple states to be represented at the same time.


To achieve this, the research team plans to combine four techniques to efficiently perform large-scale quantum computations while reducing errors. These include the Variational Quantum Algorithm, which involves an iterative process in which a quantum computer proposes candidate solutions and a classical computer calculates the error and then feeds the results back to the quantum computer for refinement; the Krylov Subspace search technique, which improves computational efficiency by restricting the search to a small subspace that is likely to contain the solution; the Classical Shadow measurement technique, which enables the simultaneous estimation of multiple physical quantities; and Non-Markovian Quantum Error Mitigation, an error-mitigation technique that mathematically models quantum-computer noise patterns and removes their effects from computational results through inverse estimation.


The three institutions will contribute to the research by leveraging their respective expertise. As the lead research institution, Seoul St. Mary’s Hospital will oversee clinical data acquisition and validation, obtain computed tomography (CT) images and data on clinical course and prognosis, prospectively follow patients, and validate the final results using 4D Flow MRI. The University of Seoul will be responsible for quantum algorithm development, implementing a quantum solver that combines the four techniques and generating performance metrics to quantitatively determine whether quantum advantage is achieved. FLONICS will validate the accuracy of quantum CFD using Flonics-Streamliner, its proprietary 4D Flow MRI-based automated blood-flow analysis platform. 


Professor Doyeol Ahn explained the significance of the research, stating, “We will go beyond demonstrating the theoretical potential of quantum algorithms and quantitatively determine how far circuit resources and the number of measurements can be reduced while maintaining the target accuracy.” Professor Jong-Chan Youn, the principal investigator, said, “Although personalized diagnosis and treatment based on hemodynamics are key to overcoming cardiovascular disease, they have not yet been fully implemented in clinical practice. By applying quantum algorithms and error-mitigation techniques to the CFD solver stage, which is a major bottleneck and the most computationally intensive stage, we aim to identify the conditions under which quantum advantage can be achieved in actual clinical practice.” Director Kyuhan Lee stated, “We plan to expand the verification framework established in this study to other cardiovascular diseases and various medical imaging–based diagnostic software applications in the future.”


This research is expected to mark a significant first step in expanding quantum computing–based CFD technology beyond cardiovascular diseases to cerebrovascular disease diagnosis, biomedical device design, and medical digital twin–based precision medicine. Furthermore, with the global cardiovascular medical technology market projected by Custom Market Insights to reach approximately KRW 140 trillion (USD 97.4 billion) by 2032, the research is also expected to contribute to strengthening industrial competitiveness.


Meanwhile, before being selected for this national project, the research team led by Professors Doyeol Ahn, Jung Im Jung, and Jong-Chan Youn had already demonstrated the validity of their research direction on the international stage. In 2025, they were the only team from South Korea selected for the NIH Quantum Computing Challenge, organized by the National Center for Advancing Translational Sciences (NCATS) under the U.S. National Institutes of Health (NIH), and in 2026, they were the only team from Korea selected for the Quantum Innovation Catalyzer Program, jointly organized by Cleveland Clinic and global investment firm K5 Global, thereby enhancing the international standing of Korea’s quantum medicine research. 


In particular, Professor Doyeol Ahn has developed a quantum algorithm for solving the Navier–Stokes equations, whose existence and smoothness problem is one of the seven Millennium Prize Problems, and has established a theoretical model that improves the reliability of quantum computing results using a Non-Markovian quantum error mitigation (QEM) cost function that he proposed. The quantum computing–based CFD model developed through this research is expected to represent a significant academic advancement not only in precision medicine—including CT-FFR analysis for cardiovascular disease diagnosis and tumor microcirculation–based drug delivery modeling—but also in expanding the practical applicability of quantum computing. 


The findings of this study also have significant potential for application to various core technologies of the Fourth Industrial Revolution that require the solution of nonlinear fluid dynamics equations, including precision medicine, high-speed aerodynamic flow analysis, heat exchanger design, and climate prediction.


In addition, Professor Doyeol Ahn’s related prior research was supported by the “Development of Quantum Computing Algorithms for Hypersonic Flow Analysis” project, funded by the Air Force Office of Scientific Research (AFOSR) under the U.S. Air Force Research Laboratory, and the “Development and Application of Low-Overhead, High-Efficiency Quantum Error Mitigation Technologies in NISQ Environments” project, funded by the Ministry of Science and ICT (with total funding of KRW 3.25 billion).


Distinguished Professor Emeritus Doyeol Ahn was elected an IEEE Fellow in 2005 and an American Physical Society (APS) Fellow in 2009 in recognition of his world-class research achievements in semiconductor lasers and quantum information and communications. He received the Distinguished Alumni Award from the University of Illinois Urbana-Champaign (UIUC) in 2016. To date, he has published approximately 250 SCI-indexed papers and holds approximately 40 international patents.



△From left: Professor Jung Im Jung, Professor Jong-Chan Youn, and Professor Choi Young of Seoul St. Mary’s Hospital; Distinguished Professor Emeritus Doyeol Ahn of the University of Seoul; and Kyuhan Lee, Director of the Research Institute at FLONICS